Erythromycin Topical Gel 2% Recalled Due to Failed Impurity Specifications
Teligent Pharma, Inc. is recalling Erythromycin Topical Gel 2% due to failed impurities and degradation specifications. The recall affects approximately 22,824 tubes distributed nationwide.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is an FDA Class III recall for a manufacturing/specification defect with no reported illnesses or injuries mentioned in the source. Per the rubric, FDA Class III recalls are typically scored 1 or 2; the specification failure (impurities and degradation) represents a quality control issue warranting a Moderate score rather than Low.
Plain-English summary
Teligent Pharma, Inc. is recalling Erythromycin Topical Gel 2% in 30 g and 60 g tubes due to failed impurities and degradation specifications.
The affected products are: - Erythromycin Topical Gel 2%, 30 g (NDC 52565-033-30), Lot 14010, Exp July 2021 - Erythromycin Topical Gel 2%, 60 g (NDC 52565-033-60), Lot 13865, Exp June 2021 and Lot 14011, Exp July 2021
Approximately 22,824 tubes have been distributed nationwide. The product is manufactured by Teligent Pharma, Inc. in Buena, NJ.
Consumers should discontinue use of the recalled product. Healthcare providers and patients with questions should contact their healthcare provider or pharmacist for guidance.
The recalled product
- Product
- Erythromycin Topical Gel, 2%, Net Wt. (a) 30 g,(NDC 52565-033-30) (b) 60 g,(NDC 52565-033-60) Rx Only, Manufactured by: Teligent Pharma, Inc. , Buena, NJ 08310,
- Manufacturer
- Teligent Pharma, Inc.
- Category
- Drug — Topical Antibiotic
- Hazard
- failed-impurity-specifications
- degradation
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (6)
- 1) NDC 52565-033-30 Lot 14010
- Exp July 2021
- 2) NDC 52565-033-60 Lot 13865
- Exp June 2021
- Lot 14011
- Exp July 2021.
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- HighBeak & Skiff Alcohol Antiseptic Sanitizer recalled for acetaldehyde contamination
FDA (Drugs) · 2026-06-17
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- SevereAtomoxetine Capsules Recalled Due to Labeling Mix-Up Error
FDA (Drugs) · 2026-05-27
- SevereCIMZIA injection recalled due to lack of sterility assurance
FDA (Drugs) · 2026-05-27